Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of oral octreotide capsules versus injectable somatostatin receptor ligands for maintenance of biochemical control in acromegaly
2015-002854-11Phase 3Completed
- Sponsor
- Chiasma
- Start
- Feb 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of octreotide and lanreotide in acromegaly (2 arms), sponsored by Chiasma. Primary endpoint: Maintenance of biochemical control. Started Feb 2016; status: completed.
02
Drugs
octreotidelanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2015-002854-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002854-11.